A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...

Sutro Biopharma was once worth $1 billion, another Bay Area biotech company with deep coffers and a novel research plan. And ...

A Rockville clinical-stage biotech has closed a $50 million Series B round to advance its potential treatments for cancer and ...

A drug developer planning to seek FDA approval for its first drug before the end of the year has signed a 32,000-square-foot ...

Patient advocacy groups asked the U.K.’s antitrust regulator to investigate several large drugmakers and their lobbying ...

IBB offers diversified exposure to the biotech sector, focusing on large-cap leaders while maintaining positions in smaller ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter: Agios ...

Harmony Biosciences Holdings (HRMY) is in the spotlight after announcing that its Phase 3 RECONNECT study for ZYN002 in Fragile X syndrome did not meet its main goal, citing higher than expected ...

Irish biotech start-up Aerska has raised $21 million (€18 million) in seed funding to help develop ribonucleic acid-based ...

Symbio Bioculinary does not concern submission combat or landscaping businesses, it upcycles food waste to tackle the over 30 ...

Englewood biotech SpotitEarly partners with Hackensack Meridian to study AI and canine-powered breath tests for early cancer ...

AbCellera (ABCL) has pivoted to in-house drug development, with two Phase 1 assets and a recent share price surge despite ...